Bolt Biotherapeutics (BOLT) Cash from Financing Activities (2020 - 2026)
Bolt Biotherapeutics' Cash from Financing Activities was $19,000 in Q2 2026, up 35.7% from $14,000 a year earlier and up 216.7% from the prior quarter.
Powered by 
Analysis
Bolt Biotherapeutics (BOLT) Cash from Financing Activities (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Bolt Biotherapeutics' Cash from Financing Activities was $30,000 through Jun 30, 2026, down 30.2% year-over-year.
- Cash from Financing Activities has now declined for four consecutive years, with a five-year compound annual growth rate of -78.3% (FY2020 to FY2025).
- In earlier years, Cash from Financing Activities was $108,000 in FY2024 (-57.3%), $253,000 in FY2023 (-49.7%), $503,000 in FY2022 (-99.8%) and $311.11 million in FY2021 (+685.7%).
- The Q2 2026 figure marks the highest quarterly Cash from Financing Activities since Q4 2024.
- Compared with a year earlier, Cash from Financing Activities was higher in 1 of the last four quarters, with an average decline of 50.5%.
- The best year-over-year quarter for Cash from Financing Activities over five years was Q2 2026 (growth of 35.7%); the worst was Q1 2022 (a decline of 100.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Bolt Biotherapeutics | 7.09 Mn | 7.09 Mn | - | 19,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19,000.00 |
| Mar 31, 2026 | 6,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Dec 31, 2024 | 29,000.00 |
| Jun 30, 2024 | 79,000.00 |
| Dec 31, 2023 | 106,000.00 |
| Dec 31, 2022 | 144,000.00 |
| Jun 30, 2022 | 252,000.00 |
| Mar 31, 2022 | 107,000.00 |
| Dec 31, 2021 | 495,000.00 |
| Sep 30, 2021 | 185,000.00 |
| Jun 30, 2021 | 13.41 Mn |
| Mar 31, 2021 | 297.02 Mn |
| Dec 31, 2020 | -1.07 Mn |
| Sep 30, 2020 | -923,000.00 |
| Jun 30, 2020 | 41.55 Mn |
| Mar 31, 2020 | 34,000.00 |
API Access
Bolt Biotherapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=BOLT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "BOLT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=BOLT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();